Investors

Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

> Discover our pipeline

Want to talk to our CEO?

Microbiome & us
News
Apr 8, 2022
YSOPIA Bioscience Announces the Appointment of Dr. Jean-Pierre Lehner as New Chairman of the Board of Directors |...
> more
Apr 8, 2022
YSOPIA Bioscience annonce la nomination du Dr. Jean-Pierre Lehner comme nouveau Président du Conseil d’Administration...
> more
Press / Media
Apr 14, 2022
     Fabrice Guez, CEO et CFO d’Ysopia Bioscience Observation au microscope de la morphologie de bactéries...
> more
Mar 15, 2022
Le fonds Health for Life Capital II™ et les sociétés de son portefeuille ont connu une année 2021 exceptionnelle....
> more
Publications
Apr 11, 2022
Karima Relizani, Katy Le Corf, Camille Kropp, Rebeca Martin-Rosique, Déborah Kissi, Guillaume Déjean, Lisa...
> more
Feb 16, 2022
Samuel Bellais, Mélanie Nehlich, Maryne Ania, Aurore Duquenoy, Wilfrid Mazier, Ger van den Engh, Jan Baijer, Nicole...
> more
now on twitter
YSOPIA Bioscience

Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand… t.co/jkL4ih4dFA

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions